Nuveen’s Burning Rock Biotech BNR Stock Holding History

Nuveen’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$644	Buy	+34	New	+$376	﹤0.01%	4964
2022 Q4	–	Sell	-5,200	Closed	-$124K	–	3191
2022 Q3	$124K	Hold	5,200	–	–	﹤0.01%	3144
2022 Q2	$151K	Hold	5,200	–	–	﹤0.01%	3173
2022 Q1	$483K	Buy	5,200 +420	+9%	+$36.5K	﹤0.01%	3027
2021 Q4	$456K	Sell	4,780 -2,660	-36%	-$364K	﹤0.01%	3090
2021 Q3	$1.33M	Buy	7,440 +500	+7%	+$111K	﹤0.01%	2864
2021 Q2	$2.04M	Buy	+6,940	New	+$2.05M	﹤0.01%	2701

Other funds holding BNR

Almanack Investment Partners Wayne, Pennsylvania $833M AUM 25.48% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Nuveen's BNR Position: Q3 2026 in Review

Nuveen opened a new position in Burning Rock Biotech (BNR) in Q3 2026: 34 shares worth $644. The stake represents ﹤0.01% of the portfolio and ranks #4964 among its holdings. This is a return to the name: Nuveen previously reported a position in BNR as recently as Q3 2022.

Nuveen first reported a position in BNR in Q2 2021 and has held it in 7 quarters since. The position peaked at $2.04M in Q2 2021. 4 funds tracked by Wall St. Rank hold BNR as of Q3 2026.

Nuveen held 34 shares of Burning Rock Biotech worth $644 as of Q3 2026.
Burning Rock Biotech was a new Nuveen position in Q3 2026.
Burning Rock Biotech made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4964 holding.
Nuveen first reported a position in Burning Rock Biotech in Q2 2021 and has held it in 7 quarters since.
Nuveen's Burning Rock Biotech position peaked at $2.04M in Q2 2021.
4 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.